Cartalax Protocol
Dosing & Research
Last Updated: September 4, 2026
Chemical Identity
- Amino Acid Sequence
- Ala-Glu-Asp
- Molecular Formula
- C12H19N3O8
- Molecular Weight
- 333.29 g/mol
Cartilage repair studies, Chondroprotection, Osteoarthritis models, Extracellular matrix research
Half-Life
Short (tripeptide)
Administration
• Subcutaneous
• Oral
Frequency
Once daily (injection); 1-2 capsules 1-2x daily (oral)
How It Works
- Cartilage repair studies
- Chondroprotection
- Osteoarthritis models
- Extracellular matrix research
Dosing Structure
Dose
2mg/day
Frequency
Once daily (injection); 1-2 capsules 1-2x daily (oral)
Notes
Injection: 2mg per day. Oral: ~21mg capsules, take 1-2 capsules 1-2 times per day. Cycle: 30 days on, 4 months off. Break: 3-6 months between courses. Typically administered as defined courses (10–20 days) repeated 1–2x per year, rather than continuous daily dosing. Based on Khavinson Institute and associated Russian clinical research.
Example Protocols
Dose: 2mg/day
Frequency: Once daily (injection); 1-2 capsules 1-2x daily (oral)
Duration: 30 Days On, 4 Months Off
Off Period: Not listed
Find Research Grade Cartalax
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
Injection: 2mg per day.
•
Oral: ~21mg capsules, take 1-2 capsules 1-2 times per day.
•
Cycle: 30 days on, 4 months off.
•
Break: 3-6 months between courses.
•
Typically administered as defined courses (10–20 days) repeated 1–2x per year, rather than continuous daily dosing.
•
Based on Khavinson Institute and associated Russian clinical research.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.